Aspo: Earnings to remain relatively high - Evli
This is a third party research report and does not necessarily reflect our views or values
Aspo’s record high H1 results are to face headwinds in H2, but in our view EBIT may well stay above EUR 40m also next year thanks to ESL and developments in Leipurin.